Gostout Christopher J. 4
4 · Apollo Endosurgery, Inc. · Filed Mar 2, 2018
Insider Transaction Report
Form 4
Gostout Christopher J.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-02-28$6.58/sh+14,050$92,449→ 14,050 totalExercise: $6.58From: 2019-02-28Exp: 2028-02-28→ Common Stock (14,050 underlying) - Award
Common Stock
2018-02-28+2,537→ 7,348 total
Footnotes (2)
- [F1]Represents grant of restricted stock units payable solely in common stock that vest in annual installments over four years from the grant date.
- [F2]The shares underlying the option shall vest as to 25% on the first anniversary of the grant date and the remainder will vest in equal monthly installments over the following three years.